comparemela.com
Home
Live Updates
Coeptis Therapeutics to acquire cell therapies from Deverra Therapeutics : comparemela.com
Coeptis Therapeutics to acquire cell therapies from Deverra Therapeutics
The company's shares rose 10% after it announced plans to acquire a cell therapy in phase one clinical trials.
Related Keywords
Karolinska Institutet ,
David Mehalick ,
Colleen Deaney ,
Deverra Therapeutics Inc ,
University Of Pittsburgh ,
Coeptis Therapeutics Holdings Inc ,
Nasdaq ,
Deverra Therapeutics ,
comparemela.com © 2020. All Rights Reserved.